TP53 and cancer: Mechanistically, sirtuins such as SIRT1 are able to deacetylate p53 leading to the inhibition of its DNA damage functions [91] or to induce the hypoacetylation of the DNA repair enzyme Ku70, enhancing its non-homologous end joining DNA repair ability [92,93] and allowing the survival of cancer cells [21].